Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Gilead Sciences    GILD

GILEAD SCIENCES (GILD)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201420152016201720182019
Sales24 89032 63930 39025 81622 25621 750
EBITDA16 79423 66820 34716 73613 28812 531
Operating profit (EBIT)16 58023 39620 03315 66112 49812 120
Pre-Tax Profit (EBT)------
Net income12 10118 10813 50110 5117 6898 009
P/E ratio12,88,507,209,7512,712,6
EPS ( $ )7,3511,99,947,785,976,02
Dividend per Share ( $ )-1,291,842,052,192,34
Yield-1,27%2,57%2,71%2,88%3,08%
Reference price ( $ )94.26101.1971.6175.8875.8875.88
Announcement Date02/03/2015
09:05pm
02/02/2016
09:00pm
02/07/2017
09:01pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201420152016201720182019
Debt2 8117 573-12 74210 1859 292
Finance--32 380---
Operating income (EBITDA)16 79423 66820 34716 73613 28812 531
Leverage
(Debt/EBITDA)
0,17x0,32x-0,76x0,77x0,74x
Capital Expenditure557747748554533532
Book Value Per Share (BVPS)10,6 $13,2 $14,6 $19,8 $23,9 $25,5 $
Cash Flow per Share7,79 $12,9 $12,3 $9,48 $7,28 $7,13 $
Announcement Date02/03/2015
09:05pm
02/02/2016
09:00pm
02/07/2017
09:01pm
---
Balance Sheet Analysis
Assessed data source :
© 2017 Thomson Reuters
Financial Ratios

Size 2017e 2018e
Capitalization 99 094 M$ -
Entreprise Value (EV) 111 836 M$ 109 279 M$
Valuation 2017e 2018e
P/E ratio (Price / EPS) 9,75x 12,7x
Capitalization / Revenue 3,84x 4,45x
EV / Revenue 4,33x 4,91x
EV / EBITDA 6,68x 8,22x
Yield (DPS / Price) 2,71% 2,88%
Price to book (Price / BVPS) 3,83x 3,17x
Profitability 2017e 2018e
Operating Margin (EBIT / Sales) 60,7% 56,2%
operating Leverage (Delta EBIT / Delta Sales) -1,45x -1,46x
Net Margin (Net Profit / Revenue) 40,7% 34,5%
ROA (Net Profit / Asset) 18,9% 14,2%
ROE (Net Profit / Equities) 57,9% 41,3%
Rate of Dividend 26,4% 36,7%
Balance Sheet Analysis 2017e 2018e
CAPEX / CA   2,15% 2,40%
Cash Flow / Sales 48,0% 42,7%
Capital Intensity (Assets / Sales) 2,16x 2,44x
Financial Leverage (Net Debt / EBITDA) 0,76x 0,77x
EPS & Dividend